FDMT (4D Molecular Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades

4D Molecular Therapeutics, Inc. Common Stock (FDMT) is a publicly traded Healthcare sector company. As of May 21, 2026, FDMT trades at $8.49 with a market cap of $437.29M and a P/E ratio of -3.28. FDMT moved +0.89% today. Year to date, FDMT is +16.03%; over the trailing twelve months it is +120.00%. Its 52-week range spans $2.24 to $12.34. Analyst consensus is strong buy with an average price target of $29.00. Rallies surfaces FDMT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded FDMT stock?

Rallies tracks politician and congressional stock disclosures for FDMT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

FDMT Key Metrics

Key financial metrics for FDMT
MetricValue
Price$8.49
Market Cap$437.29M
P/E Ratio-3.28
EPS$-2.57
Dividend Yield0.00%
52-Week High$12.34
52-Week Low$2.24
Volume59
Avg Volume0
Revenue (TTM)$88.24M
Net Income$-160.90M
Gross Margin0.00%

Latest FDMT News

Recent FDMT Insider Trades

  • Gupta Ashoo sold 310 (~$2.67K) on Mar 20, 2026.
  • Gupta Ashoo sold 80 (~$688.8) on Mar 20, 2026.
  • Gupta Ashoo sold 310 (~$2.69K) on Dec 20, 2025.

FDMT Analyst Consensus

9 analysts cover FDMT: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.00.

Common questions about FDMT

Which politicians traded FDMT stock?
Rallies tracks politician and congressional stock disclosures for FDMT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in FDMT?
Yes. Rallies tracks politician and congressional stock disclosures for FDMT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is FDMT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FDMT. It does not provide personalized investment advice.
FDMT

FDMT